Market Overview and Growth Outlook
The bioresorbable polymers market reached US$560 million in 2025 and is expected to reach US$1.1 billion by 2031. The market’s growth trajectory is tied to medical applications where materials must deliver temporary performance, maintain biocompatibility, degrade at controlled rates, and ultimately be absorbed by the body after completing their intended purpose.
The bioresorbable polymers market is expected to grow at a CAGR of 12% during 2025-2031. Expanding use in minimally invasive procedures, tissue engineering, regenerative medicine, orthopedic applications, and controlled drug delivery is broadening commercial adoption. These applications benefit directly from the ability to avoid permanent implants or later device-removal procedures.
The direction of bioresorbable polymers market growth is therefore closely linked to clinical functionality rather than material substitution alone. Orthopedic fixation, sutures, cardiovascular stents, scaffolds, and drug delivery systems each use the controlled degradation characteristics of these polymers differently, creating several medical pathways for continued industry expansion.
Request a free sample report:
https://www.stratviewresearch.com/Request-Sample/bioresorbable-polymers-market#form
Market Segmentation Analysis
By Type, the market is divided into Polylactic acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), and Polycaprolactone (PCL). PLA is the largest segment because its availability, cost-effectiveness, mechanical properties, biocompatibility, and established usage in orthopedic implants and sutures support broad commercial adoption in regulated healthcare environments.
Polycaprolactone (PCL) is the fastest-growing type segment. Its slow degradation profile, mechanical strength, and biocompatibility align particularly well with tissue engineering, regenerative medicine, and long-term implants. These functional properties are accelerating demand and allowing PCL to gain adoption faster than PLA, PGA, or PLGA within the source’s market analysis.
By Application, segmentation includes Orthopedic Devices and Drug Delivery. Orthopedic applications use bioresorbable polymers in screws, pins, plates, and related temporary fixation products. Drug Delivery is identified as the fastest-growing segment because the polymers can facilitate controlled therapeutic release, improve bioavailability, and avoid a separate procedure to remove the delivery device.
Regional Market Insights
Asia-Pacific represents the fastest-growing regional market. Growth is supported by rising healthcare spending, medical tourism, and rapid adoption of advanced medical devices. The source also highlights investment in modern hospitals, regulatory support, and innovative treatments in China, India, and Southeast Asian countries as factors accelerating bioresorbable implant and drug delivery adoption.
Emerging Trends Shaping the Bioresorbable Polymers Market
One structural trend is the convergence of biomaterials with regenerative medicine. DSM Biomedical and Xilloc Medical formed a strategic partnership focused on PCL-based bioresorbable scaffolds for tissue repair and bone healing, combining biomaterials engineering with 3D printing and related technologies. This development illustrates how bioresorbable polymers are being integrated into increasingly specialized regenerative applications.
Another trend is investment in medical-grade polymer capacity and performance. Evonik expanded RESOMER production, while Corbion introduced high-purity PLA with improved mechanical strength and controlled degradation characteristics. Ashland’s acquisition of Seqens’ bioresorbable polymer division further shows strategic interest in strengthening positions in advanced drug delivery and surgical systems.
Key Growth Drivers of the Market
- Orthopedic fixation demand: Bioresorbable screws, pins, plates, and other fixation devices provide temporary structural support while safely degrading, supporting their use across orthopedic applications.
- Reduced need for secondary procedures: Integration of bioresorbable devices can eliminate later removal procedures, improving their practical value in temporary implant applications.
- Regenerative applications: Tissue engineering, scaffolds, tissue repair, and bone healing create growing demand for polymers designed to combine mechanical performance with controlled degradation.
- Controlled therapeutics: Drug delivery systems benefit from controlled release, improved bioavailability, and absorbable material platforms, expanding polymer use beyond structural medical devices.
- Material-science progress: Improved purity, tailored degradation rates, and enhanced mechanical strength support next-generation applications and broaden the available medical-material portfolio.
Competitive Landscape
Top Companies in the Market
- Corbion N.V.
- Evonik Industries AG
- DSM Biomedical
- Poly-Med Inc
- Ashland Global Holdings Inc.
- KLS Martin Grou
- Foster Corporation
- Zeus Industrial Products Inc.
- SEQENS SAS
- Reva Medical LLC
The competitive landscape remains moderately fragmented, with more than 80 participants. Price, service offerings, and regional presence are among the factors governing competition. Capacity expansion, material innovation, regenerative-medicine partnerships, and specialty-polymer acquisitions show how companies are pursuing different routes to reinforce their involvement in this growing medical-material market.
Conclusion and Strategic Outlook
From US$560 million in 2025 to an expected US$1.1 billion in 2031, the bioresorbable polymers market is projected to grow at 12% annually. The combination of orthopedic applications, regenerative medicine, minimally invasive procedures, drug delivery, and continuing polymer innovation provides the structural foundation for the industry outlook through the forecast period.
FAQs – Bioresorbable Polymers Market
1. What is the current and forecast market value?
The bioresorbable polymers market stood at US$560 million in 2025. It is expected to increase to US$1.1 billion by 2031.
2. What CAGR is forecast through 2031?
The bioresorbable polymers market is expected to expand at a CAGR of 12%. This forecast covers the 2025-2031 period.
3. Why is demand for bioresorbable polymers increasing?
Demand is supported by minimally invasive procedures, tissue engineering, regenerative medicine, orthopedic fixation, and controlled drug delivery. Their controlled degradation can also reduce the requirement for secondary device-removal procedures.
4. Which geographic market is expanding fastest?
Asia-Pacific is the fastest-growing regional market. Rising healthcare spending, medical tourism, advanced-device adoption, and investment in healthcare infrastructure are identified regional growth factors.
5. What competitive factors could influence investment decisions?
The market has more than 80 participants and is moderately fragmented, with competition involving price, services, and regional presence. Strategic developments also include production expansion, partnerships, new material development, and acquisitions.
